Sofosbuvir + ribavirin for 24 weeks is highly effective against HCV genotype 4
Early antiretroviral treatment reduces risk of AIDS and HIV-related illness
PCR testing reveals high prevalence of CNS infections among people living with HIV in Zambia with CNS symptoms
Methadone and buprenorphine-naloxone both associated with reduced HIV risk among people who inject drugs
Implementation of a comprehensive harm reduction programme curtailed the HIV epidemic among people who inject drugs in Taiwan
HIV infection increases risk of melanoma
Three-drug AbbVie combination safe and highly effective in treatment of post-transplant hepatitis C recurrence
Sofosbuvir for hepatitis C works well despite multiple negative predictive factors
